Literature DB >> 9723787

Induction of burst firing in ventral tegmental area dopaminergic neurons by activation of serotonin (5-HT)1A receptors: WAY 100,635-reversible actions of the highly selective ligands, flesinoxan and S 15535.

F Lejeune1, M J Millan.   

Abstract

This study examined the influence of the highly selective 5-HT1A receptor ligands, flesinoxan, S 15535, and WAY 100,635, upon the electrical activity of dopaminergic neurons in the ventral tegmental area (VTA), as compared to serotonergic neurons in the dorsal raphe nucleus (DRN) of anesthetized rats. Flesinoxan, a high-efficacy agonist at both pre- and postsynaptic 5-HT1A receptors, dose-dependently (inhibitory dose (ID)50 = 19.5 microg/kg, i.v.) inhibited the firing of DRN serotonergic neurons. This action was abolished by WAY 100,635 (31 microg/kg i.v.) which is an antagonist at pre- and postsynaptic 5-HT1A receptors. S 15535, which behaves as an agonist and partial agonist at pre- and postsynaptic 5-HT1A receptors, respectively, similarly abolished DRN firing in a WAY 100,635-reversible fashion with an ID50 of 6.1 microg/kg, i.v. In contrast to these actions, both flesinoxan (> or = 500 microg/kg, i.v.) and S 15535 (> or = 125 microg/kg, i.v.) dose-dependently and monophasically increased the firing rate of dopaminergic neurons in the VTA, with maximal effects of 70.1 +/- 17.2% and 33.7 +/- 5.3%, respectively. Further, VTA dopaminergic neurons displaying a regular firing pattern were transformed into a bursting mode. This influence of flesinoxan and S 15535 on VTA cells was abolished by WAY 100,635. Administered alone, WAY 100,635 did not significantly modify the activity of either serotonergic or dopaminergic neurons. In conclusion, the present findings show that selective activation of 5-HT1A receptors not only inhibits serotonergic neurones but also elicits a (possibly related) increase in VTA dopaminergic output. A facilitatory influence of flesinoxan, S 15535, and other selective 5-HT1A receptor ligands upon mesocortical dopaminergic pathways may contribute to their putative antidepressant properties.

Entities:  

Mesh:

Substances:

Year:  1998        PMID: 9723787     DOI: 10.1002/(SICI)1098-2396(199810)30:2<172::AID-SYN7>3.0.CO;2-9

Source DB:  PubMed          Journal:  Synapse        ISSN: 0887-4476            Impact factor:   2.562


  11 in total

1.  Role of serotonin in cocaine effects in mice with reduced dopamine transporter function.

Authors:  Yolanda Mateo; Evgeny A Budygin; Carrie E John; Sara R Jones
Journal:  Proc Natl Acad Sci U S A       Date:  2003-12-22       Impact factor: 11.205

2.  Evidence for topographically organized endogenous 5-HT-1A receptor-dependent feedback inhibition of the ascending serotonin system.

Authors:  Kathryn G Commons
Journal:  Eur J Neurosci       Date:  2008-05-29       Impact factor: 3.386

3.  Role of somatodendritic and postsynaptic 5-HT₁A receptors on learning and memory functions in rats.

Authors:  Saida Haider; Saima Khaliq; Saiqa Tabassum; Darakhshan J Haleem
Journal:  Neurochem Res       Date:  2012-07-20       Impact factor: 3.996

Review 4.  Pharmacologic mechanisms of serotonergic regulation of dopamine neurotransmission.

Authors:  K D Alex; E A Pehek
Journal:  Pharmacol Ther       Date:  2006-10-17       Impact factor: 12.310

5.  Serotonin (5HT), fluoxetine, imipramine and dopamine target distinct 5HT receptor signaling to modulate Caenorhabditis elegans egg-laying behavior.

Authors:  Catherine M Dempsey; Scott M Mackenzie; Andrew Gargus; Gabriela Blanco; Ji Ying Sze
Journal:  Genetics       Date:  2005-01-16       Impact factor: 4.562

6.  Serotonin1B heteroreceptor activation induces an antidepressant-like effect in mice with an alteration of the serotonergic system.

Authors:  Franck Chenu; Denis J P David; Isabelle Leroux-Nicollet; Erwan Le Maître; Alain M Gardier; Michel Bourin
Journal:  J Psychiatry Neurosci       Date:  2008-11       Impact factor: 6.186

7.  Modeling considerations for 11C-CUMI-101, an agonist radiotracer for imaging serotonin 1A receptor in vivo with PET.

Authors:  Matthew S Milak; Alin J Severance; R Todd Ogden; Jaya Prabhakaran; J S Dileep Kumar; Vattoly J Majo; J John Mann; Ramin V Parsey
Journal:  J Nucl Med       Date:  2008-03-14       Impact factor: 10.057

8.  Both acute and chronic buspirone treatments have different effects on regional 5-HT synthesis in Flinders Sensitive Line rats (a rat model of depression) than in control rats.

Authors:  Kyoko Nishi; Kazuya Kanemaru; Shu Hasegawa; Arata Watanabe; Mirko Diksic
Journal:  Neurochem Int       Date:  2008-11-25       Impact factor: 3.921

9.  The selective 5-HT1A receptor antagonist WAY-100635 inhibits neuronal activity of the ventromedial prefrontal cortex in a rodent model of Parkinson's disease.

Authors:  Jian Cao; Jian Liu; Qiao-Jun Zhang; Tao Wang; Shuang Wang; Ling-Na Han; Qiang Li
Journal:  Neurosci Bull       Date:  2007-11       Impact factor: 5.203

10.  Modulation of midbrain dopamine neurotransmission by serotonin, a versatile interaction between neurotransmitters and significance for antipsychotic drug action.

Authors:  J E Olijslagers; T R Werkman; A C McCreary; C G Kruse; W J Wadman
Journal:  Curr Neuropharmacol       Date:  2006-01       Impact factor: 7.363

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.